MoneyWorks4Me

Biocon informs about investors meet

17 Feb 2026 Evaluate
Pursuant to Regulation 30(6) of the SEBI Listing Regulations, Biocon has informed that the Management of the Company is participating in the Investor Conferences as per the details enclosed. The Company will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst(s)/ investor(s) meeting. The above information will also be available on the website of the Company at www.biocon.com. 

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..